Linn K. T.
- Country
- Norway
- Department
- Sørlandet Hospital, Kristiansand
Research Overview
- Phase 3 Study of Encorafenib and Cetuximab With or Without Chemotherapy Versus Standard Therapy in Metastatic BRAF V600E Mutant Colorectal Cancer
- Phase 3 Multicenter Randomized Open-label Study of Ifinatamab Deruxtecan Versus Chemotherapy in Pretreated Advanced Esophageal Squamous Cell Carcinoma
- A Phase 2/3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Visugromab in Patients with Cancer-associated Cachexia
Data & Insights
Has run more than one trial at 33 of 171 partner sites.
Specializations
Oncology Focus
This investigator specializes in colorectal cancer treatment, with particular emphasis on cases involving BRAF V600E mutations. Their research centers on exploring innovative therapeutic approaches for patients with metastatic colorectal cancer.
- BRAF-mutant colorectal cancer
- Targeted therapy approaches
- Advanced stage colorectal cancer
Their expertise extends to personalized treatment strategies based on genetic profiles in colorectal cancer.
Precision Medicine
The investigator focuses on biomarker-driven treatment approaches, specifically in the context of genetic mutations in colorectal cancer. Their work involves evaluating targeted therapeutic combinations for optimal patient outcomes.
- Molecular profiling
- Targeted therapy combinations
- Personalized treatment strategies
Their research emphasizes the importance of genetic testing in guiding treatment decisions.
Treatment Innovation
The investigator explores combination therapy approaches in colorectal cancer, including the integration of targeted agents with standard chemotherapy. Their work evaluates various treatment combinations to improve patient care.
- Novel drug combinations
- Standard of care optimization
- Treatment sequencing strategies
Their research includes evaluation of both established and innovative treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.